What Is an Ovarian Follicle and How Does It Develop?

An ovarian follicle is a tiny, fluid-filled sac in the ovary that houses an immature egg cell (oocyte) surrounded by layers of supporting cells. Each follicle is essentially a self-contained biological unit whose job is to nurture a single egg through months of growth, supply it with nutrients and hormonal signals, and eventually release it at ovulation. The journey from a microscopic dormant follicle to a fully mature one ready to ovulate involves an intricate sequence of structural changes, cell-to-cell communication, and hormonal shifts that researchers are still working to fully map.

What a Follicle Is Made Of

At its simplest, an ovarian follicle consists of an oocyte at the center, a surrounding layer of granulosa cells, and an outer sheath of connective tissue called the theca. But each of these components is more complex than it sounds. The theca layer itself has two distinct zones: an inner layer (theca interna) containing hormone-producing cells and an outer layer (theca externa) made of fibrous connective tissue. The theca also carries blood vessels, immune cells, and structural proteins. Because the granulosa layer has no blood supply of its own, the theca is the follicle’s lifeline, delivering oxygen and nutrients inward to the granulosa cells, the cumulus cells, and ultimately the oocyte itself.¹

Granulosa cells and theca cells do not just coexist passively. Laboratory studies have shown that when these two cell types are cultured together, both grow roughly twice as fast as they do alone, and the granulosa cells shift from forming flat sheets into multilayer structures with extensive surface connections between individual cells.² That mutual influence is a recurring theme throughout follicle development: no single cell type acts alone.

Where Follicles Come From

Your entire lifetime supply of follicles is assembled before or shortly after birth. During embryonic development, precursor germ cells migrate to the developing ovary, multiply, and eventually become enclosed by a layer of flat granulosa-like cells and a basement membrane, forming structures called primordial follicles. This pool of primordial follicles constitutes the ovarian reserve.³ Despite periodic claims of stem-cell-driven follicle renewal in adults, the prevailing scientific view is that no new follicles are made after the reserve is set.⁴

The size of this initial pool depends on several factors: how many germ cells were specified in the early embryo, how much they multiplied during migration to the developing gonads, and how many died during the process of follicle formation.⁵ That means a person’s reproductive potential has roots stretching back to the earliest weeks of fetal life.

Waking Up From Dormancy

Most primordial follicles sit in a state of deep dormancy for years or even decades. At any given time, only a small batch gets activated to begin growing. The balance between staying dormant and waking up is controlled by a tug-of-war between suppressor and activator signals exchanged between the oocyte and its surrounding somatic cells.⁶ If something goes wrong with the brakes on this system, the entire reserve can be activated prematurely, burning through the egg supply years ahead of schedule.

Research in mice has shown that the initial trigger comes from the somatic cells surrounding the dormant oocyte, not from the oocyte itself. Signaling within the somatic cells drives them to differentiate into granulosa cells and produce a molecule called KIT ligand. That ligand binds to receptors on the oocyte’s surface, switching on an internal signaling cascade that “wakes” the dormant egg and sets it on the path toward growth.⁷ This cross-talk between somatic cells and the oocyte is the very first molecular event in a long developmental relay.

Growing Beyond the Primordial Stage

Once activated, a primordial follicle enters a long, gonadotropin-independent growth phase. Over weeks and months, the flat granulosa cells surrounding the oocyte become cuboidal, multiply, and form multiple layers. The oocyte itself enlarges. During this early stretch, the follicle does not need signals from the pituitary gland; local growth factors within the ovary are enough to keep the process moving.

That changes as the follicle nears the transition from a preantral follicle (solid, no fluid cavity) to an antral follicle (containing a fluid-filled space called the antrum). At this point, the follicle becomes dependent on follicle-stimulating hormone (FSH) from the pituitary. Experiments in mice lacking FSH or its receptor show that follicles can grow to the preantral stage just fine, but they stall there and never form an antrum without FSH.⁸ FSH is the gatekeeper for the next chapter of follicle growth.

Local factors also continue to matter after FSH enters the picture. Growth differentiation factor 9 (GDF-9), produced by the oocyte, promotes preantral follicle growth on its own and amplifies the effect of low-dose FSH, roughly doubling the growth seen with FSH alone in laboratory culture.⁹ The oocyte, in other words, is not just a passenger. It actively steers the follicle’s growth.

How Follicles Produce Estrogen

One of the follicle’s central jobs is manufacturing estrogen, and it does this through a division of labor between its two main cell types. Theca cells, stimulated by luteinizing hormone (LH), produce androgens. Those androgens then pass inward to the granulosa cells, which, under the influence of FSH, convert them into estrogen using an enzyme called aromatase.¹⁰ Neither cell type can produce estrogen alone; the process depends on both cell populations and both pituitary hormones working together.

This “two-cell, two-gonadotropin” framework has been a foundational model in reproductive biology for decades, and its core details have held up well. The gene encoding the key enzyme for androgen production is active exclusively in theca cells, while the FSH receptor is expressed only in granulosa cells.¹¹ The strict compartmentalization means that disrupting either cell type or either hormone collapses estrogen output.

Why Most Follicles Never Make It

The vast majority of follicles that begin growing will not reach ovulation. Instead, they undergo a process called atresia, a form of programmed elimination that clears away follicles deemed nonviable. Only a tiny fraction of all growing follicles survive to become the dominant follicle that releases an egg.¹² Atresia is not a failure of the system; it is the system’s quality-control mechanism, ensuring that the oocytes most likely to succeed are the ones selected for ovulation.¹³

During the late follicular phase of each menstrual cycle, rising estrogen from the leading follicle triggers a drop in FSH. The dominant follicle, which by this stage has enough FSH receptors and local growth-factor support to survive on lower FSH levels, keeps growing. The smaller, less mature follicles cannot keep up and degenerate. This selection process typically leaves a single dominant follicle in humans, though occasionally two survive, which is how non-identical twins can occur.

The Conversation Between the Egg and Its Helpers

Inside a mature follicle, the oocyte is not floating freely. It sits within a specialized group of granulosa cells called cumulus cells, forming the cumulus-oocyte complex. The cumulus cells extend thin projections called transzonal projections (TZPs) through the protective shell (zona pellucida) surrounding the egg, establishing direct physical contact.¹⁴ Through gap junctions at the tips of these projections, the cumulus cells shuttle ions, amino acids, metabolites, and small signaling molecules to the oocyte, essentially feeding and regulating it.

The traffic is not one-way. The oocyte secretes its own factors, including GDF-9 and bone morphogenetic protein 15, which regulate cumulus cell behavior and maintain follicular balance.¹⁵ This bidirectional dialogue is essential: oocytes that lose contact with their cumulus cells develop poorly, and cumulus cells deprived of oocyte-derived signals fail to function normally. The quality of this communication is one reason why egg quality varies from follicle to follicle.

Ovulation and What Comes After

When a follicle reaches full maturity, a surge of LH from the pituitary triggers ovulation. The LH surge sets off a cascade of events inside the follicle that bears a striking resemblance to an inflammatory response. Granulosa and theca cells ramp up production of prostaglandins, chemokines, and cytokines. Immune cells already present in the ovary become activated, and additional immune cells are recruited. Together, these processes remodel the extracellular matrix, break down the follicle wall at its thinnest point, and ultimately rupture the follicle to release the oocyte.¹⁶

After the egg is expelled, the collapsed follicle transforms into a new structure called the corpus luteum. This temporary endocrine gland produces large quantities of progesterone, up to about 40 milligrams per day, which prepares the uterine lining for a potential pregnancy.¹⁷ If pregnancy does not occur, the corpus luteum degrades after roughly two weeks, progesterone drops, and menstruation follows. If implantation does occur, signals from the embryo sustain the corpus luteum until the placenta takes over hormone production.

How Doctors Measure Follicle Health

Clinicians frequently want to know how many growing follicles a person has, especially in the context of fertility treatment. The two main tools are ultrasound-based antral follicle count (AFC) and blood levels of anti-Müllerian hormone (AMH). AMH is produced by the granulosa cells of small growing follicles, and its level in the blood correlates strongly with the number of those follicles.¹⁸ In one study, AMH showed a tighter correlation with antral follicle count than either age or FSH levels did.¹⁹

A common misconception is that AMH directly measures how many eggs you have left in total. It does not. It reflects the pool of follicles that have already started growing and could potentially respond to stimulation, which is why the preferred term is “functional ovarian reserve.” Low AMH predicts a lower response to fertility drugs and a higher chance of a poor response in IVF, but it has limited power for predicting whether a person will actually get pregnant.²⁰ A low AMH value, in other words, says more about how the ovaries will respond to stimulation than about a person’s overall fertility.

Aging and the Follicle Pool

The rate of follicle loss accelerates with age, following a curve that steepens over time rather than holding steady.²¹ Along with dwindling numbers, the quality of the remaining oocytes declines. After around age 31, the chance of a successful pregnancy per cycle begins to drop, and by the late 30s and early 40s the decline becomes steep. The main culprit behind falling oocyte quality is an increase in errors during the division of chromosomes, leading to higher rates of abnormal chromosome numbers in eggs and embryos.²²

Mitochondria play a central role in this decline. They are involved both in the programmed cell death that drives follicular atresia and in the energy supply that supports healthy egg maturation. As the ovary ages, mitochondrial function deteriorates, and the organ’s physical structure stiffens due to collagen accumulation and shifts in its structural matrix.^{23 24} This stiffening is not just a bystander effect; it may directly hamper follicle growth and oocyte release, though the research connecting biomechanics to egg quality is still young.

When Follicle Development Goes Wrong

Polycystic ovary syndrome (PCOS) is one of the most common disruptions of normal follicle development. In PCOS, excess androgens override the normal signaling balance, leading to follicular arrest: many small antral follicles begin growing but stall before reaching the dominant stage, so ovulation often does not occur.²⁵ Structurally, PCOS ovaries show an increased number of preantral follicles, failure of follicles to grow beyond the mid-antral stage, granulosa cell degeneration, and overgrowth of theca tissue.²⁶ The “cysts” visible on an ultrasound in PCOS are actually these stalled follicles, not true cysts.

At the other end of the spectrum is primary ovarian insufficiency (POI), in which the primordial follicle pool is depleted prematurely, leading to loss of ovarian function before age 40. The causes are varied: genetic mutations, autoimmune attack, and in some cases no identifiable reason at all, though advances in genetics have been steadily shrinking the “idiopathic” category.²⁷

Environmental Threats to Follicle Health

A growing body of evidence links certain environmental chemicals to disrupted follicle development. Endocrine-disrupting chemicals, including some pesticides, plasticizers, and compounds found in personal-care products, can interfere with estrogen and androgen signaling within the follicle. Animal studies show that these exposures can reduce follicle growth, increase atresia, lower oocyte viability, and even produce lasting effects that carry over to subsequent generations.²⁸ Cigarette smoke, heavy metals, and certain agrochemicals have also been implicated.²⁹

Translating animal findings to humans is always tricky, because exposure levels in laboratory studies tend to be higher and more controlled than real-world conditions. Still, epidemiological data increasingly point in the same direction, and concerns about aggregate low-dose exposure over many years have pushed this area of research forward.

IVF Stimulation and the Follicle

In a natural cycle, the drop in FSH after one follicle takes the lead dooms the rest. In vitro fertilization sidesteps this bottleneck by administering exogenous FSH to keep the hormone above the threshold that multiple follicles need to keep growing.³⁰ The goal is to “rescue” several follicles that would otherwise undergo atresia, so that multiple eggs can be retrieved. Medications that prevent a premature LH surge are given alongside FSH to keep the follicles growing in synchrony without triggering early ovulation.³¹

Understanding follicle biology also underpins newer fertility-preservation strategies. When cancer treatment threatens future fertility, ovarian tissue can be removed and cryopreserved. That tissue contains mainly primordial follicles but may also yield immature oocytes from small antral follicles at the cortex-medulla border; those oocytes can sometimes be matured in the laboratory.³² In cases where transplanting the tissue back would risk reintroducing cancer cells, researchers are working on growing primordial follicles entirely in the lab, from dormancy all the way to a mature egg. This remains experimental, and current culture systems still struggle to replicate the three-dimensional mechanical environment of a real ovary.³³ But the fact that it is being attempted at all speaks to how deeply follicle biology has been mapped over the past two decades, and how much still remains to be engineered.